Press Release Resilience Expands North American Capacity With The Acquisition Of Two Premier Biologics Manufacturing Facilities Resilience announces the acquisition of two biologics manufacturing facilities in North America. Click here to read the original article in Business Wire.
Press Release Resilience Establishes Multi-Product Development And Manufacturing Collaboration With Takeda’s Plasma-Derived Therapies Business Unit SAN DIEGO--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to... Read on
Press Release Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million From U.S. Department Of Defense For Botulinum Neurotoxin Treatment SAN DIEGO--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to... Read on
Press Release Resilience Joins Forces With Children’s Hospital Of Philadelphia To Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies SAN DIEGO & PHILADELPHIA--(BUSINESS WIRE)--Resilience Joins Forces with Children’s Hospital of Philadelphia to Develop Next-Generation... Read on
